Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.
Nikhil T SebastianAmy WebbKenneth W MerrellEugene J KoayAdam R WolfeLizhi ZhangTyler J WilhiteDalia ElganainyRyan RobbWei ChenJordan CloydMary DillhoffAllan TsungLaith AbushahinAnne NoonanTerence M WilliamsPublished in: Cancers (2021)
RS predicted worse LRR and OS in R-PDAC and worse LRR, DR, and OS in BR/LA-PDAC. This may select patients who would benefit from radiation and should be validated prospectively.